Shoji Nakamori
Higashi Osaka City General Hospital(JP)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, Neuroendocrine Tumor Research Advances, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)(2016)1,108 cited
- → Epithelial–mesenchymal transition in cancer development and its clinical significance(2009)797 cited
- → Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer(2018)385 cited
- → Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial(2019)328 cited
- → MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma(1994)282 cited
- → Genetic diagnosis of lymph-node metastasis in colorectal cancer(1995)280 cited